August J. John
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Acute Lymphoblastic Leukemia research
Papers in
-
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 2
- Oncology 4
- Co-authors
- Scott H. Kaufmann (2 shared papers)Antoine N. Saliba (1 shared paper)Liewei Wang (3 shared papers)Jia Yu (3 shared papers)Krishna R. Kalari (2 shared papers)Bo Qin (1 shared paper)Huanyao Gao (4 shared papers)Richard M. Weinshilboum (3 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Blood (2 papers)Nature Cancer (1 paper)Nature Medicine (1 paper)Future Oncology (1 paper)
- Partner nations
- United StatesItalyChina
In The Last Decade
August J. John
10 papers receiving 286 citations
Peers
Comparison fields: 5 of 48
- Hematology 102
- Public Health, Environmental and Occupational Health 131
- Oncology 85
- Pediatrics, Perinatology and Child Health 38
- Genetics 21
Countries citing papers authored by August J. John
This map shows the geographic impact of August J. John's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by August J. John with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites August J. John more than expected).
Fields of papers citing papers by August J. John
This network shows the impact of papers produced by August J. John. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by August J. John. The network helps show where August J. John may publish in the future.
Co-authors
The 21 scholars most cited alongside August J. John, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 108 | |
| 2 | 2023 | 67 | |
| 3 | 2020 | 40 | |
| 4 | 2022 | 23 | |
| 5 | 2020 | 19 | |
| 6 | 2022 | 12 | |
| 7 | 2023 | 8 | |
| 8 | 2022 | 7 | |
| 9 | 2011 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2025 | 0 | |
| 12 | 2024 | 0 | |
| 13 | 2026 | 0 |
About August J. John
August J. John is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 13 papers that have together received 286 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Chronic Myeloid Leukemia Treatments (2 papers), Protein Degradation and Inhibitors (2 papers), Cancer therapeutics and mechanisms (2 papers), CRISPR and Genetic Engineering (1 paper), Animal Virus Infections Studies (1 paper) and Reproductive System and Pregnancy (1 paper). The work is most often cited by research in Hematology (102 citations), Public Health, Environmental and Occupational Health (131 citations), Oncology (85 citations), Pediatrics, Perinatology and Child Health (38 citations) and Genetics (21 citations). August J. John has collaborated with scholars based in United States, Italy and China. Frequent co-authors include Scott H. Kaufmann, Antoine N. Saliba, Liewei Wang, Jia Yu, Krishna R. Kalari, Bo Qin, Huanyao Gao, Richard M. Weinshilboum, Xiujuan Zhu and Huan Zhang. Their work appears in journals such as Frontiers in Oncology, Blood, Nature Cancer, Nature Medicine and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.